Covid-19 Impact on Chronic Pain Treatment Market, Global Research Reports 2020-2021
This report covers market size and forecasts of Chronic Pain Treatment, including the following market information:
Major competitors identified in this market include Eli Lilly and Company, GlaxoSmithKline, Pfizer, Medtronic, Abbott Laboratories, Boston Scientific Corporation, Novartis AG, Johnson & Johnson, AstraZeneca PLC, Bristol-Myers Squibb, Becton, Dickinson and Company, Sanofi, etc.
Based on the Region:
- Global Chronic Pain Treatment Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Chronic Pain Treatment Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Chronic Pain Treatment Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Chronic Pain Treatment Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Major competitors identified in this market include Eli Lilly and Company, GlaxoSmithKline, Pfizer, Medtronic, Abbott Laboratories, Boston Scientific Corporation, Novartis AG, Johnson & Johnson, AstraZeneca PLC, Bristol-Myers Squibb, Becton, Dickinson and Company, Sanofi, etc.
Based on the Region:
- Asia-Pacific (China, Japan, South Korea, India and ASEAN)
- North America (US and Canada)
- Europe (Germany, France, UK and Italy)
- Rest of World (Latin America, Middle East & Africa)
- Drugs
- Devices
- Hospitals
- Clinics
- Nursing Homes
- Research Centers & Universities
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Chronic Pain Treatment Industry
1.7 COVID-19 Impact: Chronic Pain Treatment Market Trends
2 GLOBAL CHRONIC PAIN TREATMENT QUARTERLY MARKET SIZE ANALYSIS
2.1 Chronic Pain Treatment Business Impact Assessment - COVID-19
2.1.1 Global Chronic Pain Treatment Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Chronic Pain Treatment Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Chronic Pain Treatment Quarterly Market Size, 2019 VS 2020
3.2 By Players, Chronic Pain Treatment Headquarters and Area Served
3.3 Date of Key Players Enter into Chronic Pain Treatment Market
3.4 Key Players Chronic Pain Treatment Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON CHRONIC PAIN TREATMENT SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Drugs
1.4.2 Devices
4.2 By Type, Global Chronic Pain Treatment Market Size, 2019-2021
5 IMPACT OF COVID-19 ON CHRONIC PAIN TREATMENT SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Hospitals
5.5.2 Clinics
5.5.3 Nursing Homes
5.5.4 Research Centers & Universities
5.2 By Application, Global Chronic Pain Treatment Market Size, 2019-2021
5.2.1 By Application, Global Chronic Pain Treatment Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Eli Lilly and Company
7.1.1 Eli Lilly and Company Business Overview
7.1.2 Eli Lilly and Company Chronic Pain Treatment Quarterly Revenue, 2020
7.1.3 Eli Lilly and Company Chronic Pain Treatment Product Introduction
7.1.4 Eli Lilly and Company Response to COVID-19 and Related Developments
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Business Overview
7.2.2 GlaxoSmithKline Chronic Pain Treatment Quarterly Revenue, 2020
7.2.3 GlaxoSmithKline Chronic Pain Treatment Product Introduction
7.2.4 GlaxoSmithKline Response to COVID-19 and Related Developments
7.3 Pfizer
7.3.1 Pfizer Business Overview
7.3.2 Pfizer Chronic Pain Treatment Quarterly Revenue, 2020
7.3.3 Pfizer Chronic Pain Treatment Product Introduction
7.3.4 Pfizer Response to COVID-19 and Related Developments
7.4 Medtronic
7.4.1 Medtronic Business Overview
7.4.2 Medtronic Chronic Pain Treatment Quarterly Revenue, 2020
7.4.3 Medtronic Chronic Pain Treatment Product Introduction
7.4.4 Medtronic Response to COVID-19 and Related Developments
7.5 Abbott Laboratories
7.5.1 Abbott Laboratories Business Overview
7.5.2 Abbott Laboratories Chronic Pain Treatment Quarterly Revenue, 2020
7.5.3 Abbott Laboratories Chronic Pain Treatment Product Introduction
7.5.4 Abbott Laboratories Response to COVID-19 and Related Developments
7.6 Boston Scientific Corporation
7.6.1 Boston Scientific Corporation Business Overview
7.6.2 Boston Scientific Corporation Chronic Pain Treatment Quarterly Revenue, 2020
7.6.3 Boston Scientific Corporation Chronic Pain Treatment Product Introduction
7.6.4 Boston Scientific Corporation Response to COVID-19 and Related Developments
7.7 Novartis AG
7.7.1 Novartis AG Business Overview
7.7.2 Novartis AG Chronic Pain Treatment Quarterly Revenue, 2020
7.7.3 Novartis AG Chronic Pain Treatment Product Introduction
7.7.4 Novartis AG Response to COVID-19 and Related Developments
7.8 Johnson & Johnson
7.8.1 Johnson & Johnson Business Overview
7.8.2 Johnson & Johnson Chronic Pain Treatment Quarterly Revenue, 2020
7.8.3 Johnson & Johnson Chronic Pain Treatment Product Introduction
7.8.4 Johnson & Johnson Response to COVID-19 and Related Developments
7.9 AstraZeneca PLC
7.9.1 AstraZeneca PLC Business Overview
7.9.2 AstraZeneca PLC Chronic Pain Treatment Quarterly Revenue, 2020
7.9.3 AstraZeneca PLC Chronic Pain Treatment Product Introduction
7.9.4 AstraZeneca PLC Response to COVID-19 and Related Developments
7.10 Bristol-Myers Squibb
7.10.1 Bristol-Myers Squibb Business Overview
7.10.2 Bristol-Myers Squibb Chronic Pain Treatment Quarterly Revenue, 2020
7.10.3 Bristol-Myers Squibb Chronic Pain Treatment Product Introduction
7.10.4 Bristol-Myers Squibb Response to COVID-19 and Related Developments
7.11 Becton, Dickinson and Company
7.11.1 Becton, Dickinson and Company Business Overview
7.11.2 Becton, Dickinson and Company Chronic Pain Treatment Quarterly Revenue, 2020
7.11.3 Becton, Dickinson and Company Chronic Pain Treatment Product Introduction
7.11.4 Becton, Dickinson and Company Response to COVID-19 and Related Developments
7.12 Sanofi
7.12.1 Sanofi Business Overview
7.12.2 Sanofi Chronic Pain Treatment Quarterly Revenue, 2020
7.12.3 Sanofi Chronic Pain Treatment Product Introduction
7.12.4 Sanofi Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Chronic Pain Treatment Industry
1.7 COVID-19 Impact: Chronic Pain Treatment Market Trends
2 GLOBAL CHRONIC PAIN TREATMENT QUARTERLY MARKET SIZE ANALYSIS
2.1 Chronic Pain Treatment Business Impact Assessment - COVID-19
2.1.1 Global Chronic Pain Treatment Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Chronic Pain Treatment Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Chronic Pain Treatment Quarterly Market Size, 2019 VS 2020
3.2 By Players, Chronic Pain Treatment Headquarters and Area Served
3.3 Date of Key Players Enter into Chronic Pain Treatment Market
3.4 Key Players Chronic Pain Treatment Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON CHRONIC PAIN TREATMENT SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Drugs
1.4.2 Devices
4.2 By Type, Global Chronic Pain Treatment Market Size, 2019-2021
5 IMPACT OF COVID-19 ON CHRONIC PAIN TREATMENT SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Hospitals
5.5.2 Clinics
5.5.3 Nursing Homes
5.5.4 Research Centers & Universities
5.2 By Application, Global Chronic Pain Treatment Market Size, 2019-2021
5.2.1 By Application, Global Chronic Pain Treatment Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Eli Lilly and Company
7.1.1 Eli Lilly and Company Business Overview
7.1.2 Eli Lilly and Company Chronic Pain Treatment Quarterly Revenue, 2020
7.1.3 Eli Lilly and Company Chronic Pain Treatment Product Introduction
7.1.4 Eli Lilly and Company Response to COVID-19 and Related Developments
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Business Overview
7.2.2 GlaxoSmithKline Chronic Pain Treatment Quarterly Revenue, 2020
7.2.3 GlaxoSmithKline Chronic Pain Treatment Product Introduction
7.2.4 GlaxoSmithKline Response to COVID-19 and Related Developments
7.3 Pfizer
7.3.1 Pfizer Business Overview
7.3.2 Pfizer Chronic Pain Treatment Quarterly Revenue, 2020
7.3.3 Pfizer Chronic Pain Treatment Product Introduction
7.3.4 Pfizer Response to COVID-19 and Related Developments
7.4 Medtronic
7.4.1 Medtronic Business Overview
7.4.2 Medtronic Chronic Pain Treatment Quarterly Revenue, 2020
7.4.3 Medtronic Chronic Pain Treatment Product Introduction
7.4.4 Medtronic Response to COVID-19 and Related Developments
7.5 Abbott Laboratories
7.5.1 Abbott Laboratories Business Overview
7.5.2 Abbott Laboratories Chronic Pain Treatment Quarterly Revenue, 2020
7.5.3 Abbott Laboratories Chronic Pain Treatment Product Introduction
7.5.4 Abbott Laboratories Response to COVID-19 and Related Developments
7.6 Boston Scientific Corporation
7.6.1 Boston Scientific Corporation Business Overview
7.6.2 Boston Scientific Corporation Chronic Pain Treatment Quarterly Revenue, 2020
7.6.3 Boston Scientific Corporation Chronic Pain Treatment Product Introduction
7.6.4 Boston Scientific Corporation Response to COVID-19 and Related Developments
7.7 Novartis AG
7.7.1 Novartis AG Business Overview
7.7.2 Novartis AG Chronic Pain Treatment Quarterly Revenue, 2020
7.7.3 Novartis AG Chronic Pain Treatment Product Introduction
7.7.4 Novartis AG Response to COVID-19 and Related Developments
7.8 Johnson & Johnson
7.8.1 Johnson & Johnson Business Overview
7.8.2 Johnson & Johnson Chronic Pain Treatment Quarterly Revenue, 2020
7.8.3 Johnson & Johnson Chronic Pain Treatment Product Introduction
7.8.4 Johnson & Johnson Response to COVID-19 and Related Developments
7.9 AstraZeneca PLC
7.9.1 AstraZeneca PLC Business Overview
7.9.2 AstraZeneca PLC Chronic Pain Treatment Quarterly Revenue, 2020
7.9.3 AstraZeneca PLC Chronic Pain Treatment Product Introduction
7.9.4 AstraZeneca PLC Response to COVID-19 and Related Developments
7.10 Bristol-Myers Squibb
7.10.1 Bristol-Myers Squibb Business Overview
7.10.2 Bristol-Myers Squibb Chronic Pain Treatment Quarterly Revenue, 2020
7.10.3 Bristol-Myers Squibb Chronic Pain Treatment Product Introduction
7.10.4 Bristol-Myers Squibb Response to COVID-19 and Related Developments
7.11 Becton, Dickinson and Company
7.11.1 Becton, Dickinson and Company Business Overview
7.11.2 Becton, Dickinson and Company Chronic Pain Treatment Quarterly Revenue, 2020
7.11.3 Becton, Dickinson and Company Chronic Pain Treatment Product Introduction
7.11.4 Becton, Dickinson and Company Response to COVID-19 and Related Developments
7.12 Sanofi
7.12.1 Sanofi Business Overview
7.12.2 Sanofi Chronic Pain Treatment Quarterly Revenue, 2020
7.12.3 Sanofi Chronic Pain Treatment Product Introduction
7.12.4 Sanofi Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
LIST OF TABLES
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Chronic Pain Treatment Assessment
Table 9. COVID-19 Impact: Chronic Pain Treatment Market Trends
Table 10. COVID-19 Impact Global Chronic Pain Treatment Market Size
Table 11. Global Chronic Pain Treatment Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Chronic Pain Treatment Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Chronic Pain Treatment Market Growth Drivers
Table 14. Global Chronic Pain Treatment Market Restraints
Table 15. Global Chronic Pain Treatment Market Opportunities
Table 16. Global Chronic Pain Treatment Market Challenges
Table 17. By Players, Chronic Pain Treatment Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Chronic Pain Treatment Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Chronic Pain Treatment Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Chronic Pain Treatment Market
Table 21. Key Players Chronic Pain Treatment Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Chronic Pain Treatment Market Size 2019-2021, (US$ Million)
Table 24. Global Chronic Pain Treatment Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Chronic Pain Treatment Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 57. Eli Lilly and Company Business Overview
Table 58. Eli Lilly and Company Chronic Pain Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Eli Lilly and Company Chronic Pain Treatment Product
Table 60. Eli Lilly and Company Response to COVID-19 and Related Developments
Table 61. GlaxoSmithKline Business Overview
Table 62. GlaxoSmithKline Chronic Pain Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. GlaxoSmithKline Chronic Pain Treatment Product
Table 64. GlaxoSmithKline Response to COVID-19 and Related Developments
Table 65. Pfizer Business Overview
Table 66. Pfizer Chronic Pain Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Pfizer Chronic Pain Treatment Product
Table 68. Pfizer Response to COVID-19 and Related Developments
Table 69. Medtronic Business Overview
Table 70. Medtronic Chronic Pain Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Medtronic Chronic Pain Treatment Product
Table 72. Medtronic Response to COVID-19 and Related Developments
Table 73. Abbott Laboratories Business Overview
Table 74. Abbott Laboratories Chronic Pain Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Abbott Laboratories Chronic Pain Treatment Product
Table 76. Abbott Laboratories Response to COVID-19 and Related Developments
Table 77. Boston Scientific Corporation Business Overview
Table 78. Boston Scientific Corporation Chronic Pain Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Boston Scientific Corporation Chronic Pain Treatment Product
Table 80. Boston Scientific Corporation Response to COVID-19 and Related Developments
Table 81. Novartis AG Business Overview
Table 82. Novartis AG Chronic Pain Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Novartis AG Chronic Pain Treatment Product
Table 84. Novartis AG Response to COVID-19 and Related Developments
Table 85. Johnson & Johnson Business Overview
Table 86. Johnson & Johnson Chronic Pain Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Johnson & Johnson Chronic Pain Treatment Product
Table 88. Johnson & Johnson Response to COVID-19 and Related Developments
Table 89. AstraZeneca PLC Business Overview
Table 90. AstraZeneca PLC Chronic Pain Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. AstraZeneca PLC Chronic Pain Treatment Product
Table 92. AstraZeneca PLC Response to COVID-19 and Related Developments
Table 93. Bristol-Myers Squibb Business Overview
Table 94. Bristol-Myers Squibb Chronic Pain Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Bristol-Myers Squibb Chronic Pain Treatment Product
Table 96. Bristol-Myers Squibb Response to COVID-19 and Related Developments
Table 97. Becton, Dickinson and Company Business Overview
Table 98. Becton, Dickinson and Company Chronic Pain Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Becton, Dickinson and Company Chronic Pain Treatment Product
Table 100. Becton, Dickinson and Company Response to COVID-19 and Related Developments
Table 101. Sanofi Business Overview
Table 102. Sanofi Chronic Pain Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 103. Sanofi Chronic Pain Treatment Product
Table 104. Sanofi Response to COVID-19 and Related Developments
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Chronic Pain Treatment Assessment
Table 9. COVID-19 Impact: Chronic Pain Treatment Market Trends
Table 10. COVID-19 Impact Global Chronic Pain Treatment Market Size
Table 11. Global Chronic Pain Treatment Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Chronic Pain Treatment Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Chronic Pain Treatment Market Growth Drivers
Table 14. Global Chronic Pain Treatment Market Restraints
Table 15. Global Chronic Pain Treatment Market Opportunities
Table 16. Global Chronic Pain Treatment Market Challenges
Table 17. By Players, Chronic Pain Treatment Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Chronic Pain Treatment Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Chronic Pain Treatment Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Chronic Pain Treatment Market
Table 21. Key Players Chronic Pain Treatment Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Chronic Pain Treatment Market Size 2019-2021, (US$ Million)
Table 24. Global Chronic Pain Treatment Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Chronic Pain Treatment Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Chronic Pain Treatment Market Size, 2019-2021 (US$ Million)
Table 57. Eli Lilly and Company Business Overview
Table 58. Eli Lilly and Company Chronic Pain Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Eli Lilly and Company Chronic Pain Treatment Product
Table 60. Eli Lilly and Company Response to COVID-19 and Related Developments
Table 61. GlaxoSmithKline Business Overview
Table 62. GlaxoSmithKline Chronic Pain Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. GlaxoSmithKline Chronic Pain Treatment Product
Table 64. GlaxoSmithKline Response to COVID-19 and Related Developments
Table 65. Pfizer Business Overview
Table 66. Pfizer Chronic Pain Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Pfizer Chronic Pain Treatment Product
Table 68. Pfizer Response to COVID-19 and Related Developments
Table 69. Medtronic Business Overview
Table 70. Medtronic Chronic Pain Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Medtronic Chronic Pain Treatment Product
Table 72. Medtronic Response to COVID-19 and Related Developments
Table 73. Abbott Laboratories Business Overview
Table 74. Abbott Laboratories Chronic Pain Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Abbott Laboratories Chronic Pain Treatment Product
Table 76. Abbott Laboratories Response to COVID-19 and Related Developments
Table 77. Boston Scientific Corporation Business Overview
Table 78. Boston Scientific Corporation Chronic Pain Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Boston Scientific Corporation Chronic Pain Treatment Product
Table 80. Boston Scientific Corporation Response to COVID-19 and Related Developments
Table 81. Novartis AG Business Overview
Table 82. Novartis AG Chronic Pain Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Novartis AG Chronic Pain Treatment Product
Table 84. Novartis AG Response to COVID-19 and Related Developments
Table 85. Johnson & Johnson Business Overview
Table 86. Johnson & Johnson Chronic Pain Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Johnson & Johnson Chronic Pain Treatment Product
Table 88. Johnson & Johnson Response to COVID-19 and Related Developments
Table 89. AstraZeneca PLC Business Overview
Table 90. AstraZeneca PLC Chronic Pain Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. AstraZeneca PLC Chronic Pain Treatment Product
Table 92. AstraZeneca PLC Response to COVID-19 and Related Developments
Table 93. Bristol-Myers Squibb Business Overview
Table 94. Bristol-Myers Squibb Chronic Pain Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Bristol-Myers Squibb Chronic Pain Treatment Product
Table 96. Bristol-Myers Squibb Response to COVID-19 and Related Developments
Table 97. Becton, Dickinson and Company Business Overview
Table 98. Becton, Dickinson and Company Chronic Pain Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Becton, Dickinson and Company Chronic Pain Treatment Product
Table 100. Becton, Dickinson and Company Response to COVID-19 and Related Developments
Table 101. Sanofi Business Overview
Table 102. Sanofi Chronic Pain Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 103. Sanofi Chronic Pain Treatment Product
Table 104. Sanofi Response to COVID-19 and Related Developments
LIST OF FIGURES
Figure 1. Chronic Pain Treatment Product Picture
Figure 2. Chronic Pain Treatment Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Chronic Pain Treatment Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Chronic Pain Treatment Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Chronic Pain Treatment Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Chronic Pain Treatment Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Chronic Pain Treatment Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Chronic Pain Treatment Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Chronic Pain Treatment Market Size Market Share, 2019-2021
Figure 1. Chronic Pain Treatment Product Picture
Figure 2. Chronic Pain Treatment Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Chronic Pain Treatment Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Chronic Pain Treatment Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Chronic Pain Treatment Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Chronic Pain Treatment Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Chronic Pain Treatment Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Chronic Pain Treatment Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Chronic Pain Treatment Market Size Market Share, 2019-2021
